Haverhill, MA, United States of America

Shawn Schiller

USPTO Granted Patents = 18 


 

Average Co-Inventor Count = 7.5

ph-index = 9

Forward Citations = 169(Granted Patents)


Company Filing History:


Years Active: 2006-2021

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):

Title: Shawn Schiller: Collaborative Innovator Bringing Ideas to Life

Introduction:

Shawn Schiller, a talented inventor based in Haverhill, MA (US), has made significant contributions to the field of pharmaceutical research through his innovative patents. With 18 patents to his name, Shawn has showcased his expertise in developing compounds for the treatment of autoimmune diseases, most notably systemic lupus erythematosus (SLE) and lupus nephritis. Let's explore Shawn's latest patents, career highlights, and his collaborative approach to innovation.

Latest Patents:

Shawn Schiller's recent patents center around tetrahydropyrazolopyrimidine compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8. These pharmaceutical compositions show promise in effectively treating SLE and lupus nephritis. By targeting these autoimmune disorders with his inventive compounds, Shawn's work has the potential to positively impact the lives of countless patients worldwide.

Career Highlights:

With a career dedicated to scientific exploration and innovation, Shawn Schiller has established himself as a respected figure in the pharmaceutical industry. Throughout his professional journey, he has made notable contributions to companies such as Eisai R&D Management Co., Ltd. and Eisai Company, Limited. His work demonstrates a deep understanding of drug development and the potential of his inventions to address unmet medical needs.

Collaborations:

Shawn Schiller's success is not solely attributed to his own efforts, but also to his collaborative approach. He actively collaborates with industry experts, researchers, and fellow inventors, leveraging their diverse perspectives and expertise to bring his ideas to fruition. Notably, Shawn has worked alongside esteemed colleagues Lynn D Hawkins and Sally T Ishizaka, fostering an environment conducive to creativity and innovation.

By actively engaging with other professionals, Shawn ensures that his work remains at the forefront of advancements in pharmaceutical research. His collaborations have allowed him to gather insights, trigger new ideas, and enhance the efficacy of his patentable compounds.

Conclusion:

Shawn Schiller, a prolific innovator and inventor, has made significant contributions to the field of pharmaceutical research through his numerous patents. His latest inventions targeting Toll-like receptors 7 and/or 8 for the effective treatment of autoimmune diseases showcase his dedication to finding solutions for unmet medical needs. By actively collaborating with industry experts, researchers, and fellow inventors, Shawn further enhances the impact and viability of his inventions.

As Shawn continues to explore new avenues in drug development, it is clear that his passion and collaborative spirit will pave the way for more groundbreaking innovations in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…